Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asymchem Laboratories Tianjin CoASLTY 69 3-Year Book Growth Rate is 5.00% as of Mar. 2026, which is 83% below its 10-year median of 29.85. GuruFocus rates ASLTY with a GF Score™ of 69/100 and a GF Value™ of $4.92 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 1,134 Biotechnology companies, Asymchem Laboratories Tianjin Co ranks better than 71.34% on this metric.
During the past 12 months, Asymchem Laboratories Tianjin Co's average Book Value per Share Growth Rate was 4.40% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 5.00% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 19.00% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 34.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Asymchem Laboratories Tianjin Co was 65.10% per year. The lowest was -0.70% per year. And the median was 29.85% per year.
Asymchem Laboratories Tianjin Co (OTCPK:ASLTY) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Asymchem Laboratories Tianjin Co 3-Year Book Growth Rate Related Terms
ASLTY vs VRTX, REGN, RVMD: 3-Year Book Growth Rate Comparison
For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asymchem Laboratories Tianjin Co 3-Year Book Growth Rate vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Asymchem Laboratories Tianjin Co's 3-Year Book Growth Rate falls into.
Asymchem Laboratories Tianjin Co 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 5.00% mean?
Asymchem Laboratories Tianjin Co (ASLTY) has a 3-Year Book Growth Rate of 5.00% as of Mar. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Asymchem Laboratories Tianjin Co and its competitors. This is 83% below median its historical median of 29.85. According to the industry distribution chart, Asymchem Laboratories Tianjin Co ranks #325 out of 1134 companies in the Biotechnology industry, placing it in the top 28.7%.
Is Asymchem Laboratories Tianjin Co's 3-Year Book Growth Rate too high?
Asymchem Laboratories Tianjin Co's current 3-Year Book Growth Rate of 5.00% is 83% below median its 10-year median of 29.85. Based on the distribution chart, Asymchem Laboratories Tianjin Co ranks #325 out of 1134 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Asymchem Laboratories Tianjin Co has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asymchem Laboratories Tianjin Co's 3-Year Book Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Asymchem Laboratories Tianjin Co ranks #325 out of 1134 companies for 3-Year Book Growth Rate. This puts Asymchem Laboratories Tianjin Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Biotechnology company?
A good 3-Year Book Growth Rate depends on the Biotechnology industry context. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Asymchem Laboratories Tianjin Co and its competitors. Asymchem Laboratories Tianjin Co's current 3-Year Book Growth Rate is 5.00%, which is 83% below median its own 10-year median of 29.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asymchem Laboratories Tianjin Co stock overvalued right now?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co (ASLTY) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.92, compared to a current price of $7.45 — trading 51.4% above its estimated fair value. The current 3-Year Book Growth Rate is 5.00%, which is 83% below median its 10-year median of 29.85. Asymchem Laboratories Tianjin Co's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Asymchem Laboratories Tianjin Co (ASLTY), the current 3-Year Book Growth Rate is 5.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asymchem Laboratories Tianjin Co (ASLTY) Overvalued in 2026?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co stock appears to be overvalued.
The current stock price of $7.45 is trading 51.4% above its estimated GF Value™ of $4.92.
GuruFocus considers Asymchem Laboratories Tianjin Co to be Significantly Overvalued.
Key valuation signals for ASLTY:
3-Year Book Growth Rate: 5.00% (83% below median its 10-year median of 29.85)
GF Value™: $4.92 vs. price of $7.45 (51.4% above fair value)
No single metric tells the full story. See the ASLTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asymchem Laboratories Tianjin Co Business Description
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
69GF Score
Get the complete analysis for ASLTY
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASLTY has been successfully added to your 
